Cabozantinib and atezolizumab for recurrent or metastatic esophageal squamous cell carcinoma after platinum-based chemotherapy failure: a single-arm phase II study and biomarker analysis
Hung-Yang Kuo, Ta-Chen Huang, Chien-Huai Chuang, Tsung-Che Wu, Yen-Lin Huang, Chia-Chi Lin, Jang-Ming Lee, Jhe-Cyuan Guo, Chih-Hung Hsu · 2026
Read Cabozantinib and atezolizumab for recurrent or metastatic esophageal squamous cell carcinoma after platinum-based chemotherapy failure: a single-arm phase II study and biomarker analysis by Hung-Yang Kuo, Ta-Chen Huang, Chien-Huai Chuang, Tsung-Che Wu, Yen-Lin Huang, Chia-Chi Lin, Jang-Ming Lee, Jhe-Cyuan Guo, Chih-Hung Hsu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13323437.txt.
Description
Hung-Yang Kuo, Ta-Chen Huang, and Chien-Huai Chuang lead a team testing a two-drug pairing for esophageal cancer that returned after platinum chemotherapy. Their phase two study appeared in two thousand twenty-six. Immune checkpoint drugs alone help few such patients. A multikinase drug that starves tumors and stirs immunity might widen the benefit.
Twenty-four patients received the daily kinase pill plus an immune infusion every three weeks. About three in ten saw their tumors shrink. Over half achieved at least disease control for a time. Responses lasted a median of several months. Biomarker analyses accompanied the treatment data. Toxicity was tracked as a formal endpoint. As a single-arm study it cannot prove the pairing beats either drug alone. It does clear the bar for a randomized test. Esophageal patients after platinum failure have thin options.
Catalog record
| CREATOR | Hung-Yang Kuo, Ta-Chen Huang, Chien-Huai Chuang, Tsung-Che Wu, Yen-Lin Huang, Chia-Chi Lin, Jang-Ming Lee, Jhe-Cyuan Guo, Chih-Hung Hsu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |